R. Alikhan

First name
Last name
Ramagopalan, S. V., Stamp, E., Sammon, C. J., Besford, M., Carroll, R., Mehmud, F., & Alikhan, R. (2019). Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective study. Future Cardiol. http://doi.org/10.2217/fca-2019-0012
Alikhan, R., Lefevre, C., Menown, I., Lister, S., Bird, A., You, M., et al. (2019). Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink Study. TH Open. http://doi.org/10.1055/s-0039-1698413
Allan, V., Sammon, C. J., McDonald, L., Mehmud, F., Alikhan, R., & Ramagopalan, S. V. (2019). Impact of atrial fibrillation awareness campaigns: interrupted time series using the Clinical Practice Research Datalink. Future Cardiol. http://doi.org/10.2217/fca-2019-0025
Ramagopalan, S. V., Carroll, R., Ulvestad, M., Mehmud, F., & Alikhan, R. (2019). The changing face of venous thromboembolism management in England. Future Cardiol. http://doi.org/10.2217/fca-2019-0003
Ramagopalan, S. V., Samnaliev, M., Weir, S., Sammon, C. J., Carroll, R., & Alikhan, R. (2019). Costs of gastrointestinal bleeding events in atrial fibrillation: a UK Clinical Practice Research Datalink study. Future Cardiol. http://doi.org/10.2217/fca-2019-0033
Ramagopalan, S. V., Graham, S., Carroll, R., Raluy-Callado, M., Nordstrom, B. L., Donaldson, R., et al. (2019). Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarin. J Comp Eff Res. http://doi.org/10.2217/cer-2019-0005
Besford, M., Graham, S., Sammon, C., Mehmud, F., Allan, V., Alikhan, R., & Ramagopalan, S. (2020). Factors associated with non-prescription of oral anticoagulant treatment in non-valvular atrial fibrillation patients with dementia: a CPRD-HES study. Age Ageing. http://doi.org/10.1093/ageing/afaa045